Posted in Uncategorized | Leave a Comment »
SEE OUR NEW CANCER BOOK ON AMAZON.com
Editor-in-Chief: Aviva Lev-Ari, PhD, RN
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Immuno-Oncology & Genomics, Immunodiagnostics | Leave a Comment »
Two Connectionists and Two Conversationalists – Brain Science is the Expertise of First-term incoming President of Hebrew University of Jerusalem and Third-term President of Technion, Israel Institute of Technology
Reporter: Aviva Lev- Ari, PhD, RN

WordCloud Image Produced by Adam Tubman
Two Connectionists and Two Conversationalists
Professor Asher Cohen, was elected President of the Hebrew University of Jerusalem
Reporter: Aviva Lev-Ari, PhD, RN
Prof. Peretz Lavie – CV
Prof. Peretz Lavie is the 16th president of Technion – Israel Institute of Technology, having taken the position on October 1, 2009. Between 1993 and 1999, Prof. Lavie served as dean of the Rappaport Faculty of Medicine, and between 2001 and 2008, as Technion’s vice president for resource development and external relations.
Prof. Lavie is a world-respected Lavie authority on the psychophysiology of sleep and sleep disorders. He is the author of several books, including: The Enchanted World of Sleep; and Restless Nights: Understanding Sleep Apnea and Snoring. He has founded several start-up companies, including Itamar Medical Ltd.
http://pard.technion.ac.il/technion-president/
President Prof. Peretz Lavie Elected to 3rd Term
During Prof. Lavie’s current term in office (2009-2017), Technion recorded impressive achievements led by the recruitment of more than 200 new faculty members. “Outstanding faculty members are the most important asset of any university,” said Prof. Lavie. “The quality of Technion and its future status will be determined first and foremost by the quality of its faculty members.”
The new faculty members, whose recruitment involved the extensive recruitment of resources, are mostly young and were selected based on excellence in research. The increase in the number of faculty members was accompanied by a significant increase in the number of publications in the world’s leading scientific journals. In 2016, Technion was ranked 26th in the world in the list of Rising Stars, published by the leading scientific journal Nature, following a 40% increase in Technion’s publications in leading scientific journals. In the Shanghai ranking, the world’s leading index of academic institutions, within eight years Technion shot up from rank 101-152 worldwide to 69th place in 2016: the top of Israel’s universities. These rankings, along with a significant increase in the awarding of research grants, attest to Technion’s academic excellence and the research achievements of its faculty members.
The research world, in Prof. Lavie’s view, is changing. In the past, a scientist could carry out research and achieve breakthroughs on his own, but now significant research requires interdisciplinary cooperation. “The walls between disciplines, faculties, and fields of research are collapsing,” explains Prof. Lavie. “Future achievements in science and engineering will require cooperation between laboratories and researchers from different fields. In order to achieve significant scientific and engineering breakthroughs, enormous knowledge is now required — knowledge that an individual scientist does not possess.” For this reason, Technion has worked to establish interdisciplinary centers where researchers from different faculties work together. These centers include research institutes such as the Technion Integrated Cancer Center (TICC), the Quantum Engineering Center, the Cyber Security Research Center, and the Technion Computer Engineering Center (TCE), in addition to the Excellence Centers of the Council for Higher Education that have been established at Technion.
The number of students at Technion is growing steadily. In the past eight years, the number of students has increased from 12,665 (2009-2010) to 14,121 (2016-2017). In addition, there has been a 30% increase in the number of graduate students (master’s and doctoral).
Since taking office as President, Prof. Lavie has worked to change the atmosphere at Technion and its image as a rigid institution that is not sufficiently considerate of its students. Under his leadership, a committee was established to examine the structure of studies and academic load at Technion, headed by Prof. Yachin Cohen of the Faculty of Chemical Engineering. The committee’s recommendations, which were implemented in conjunction with the Technion Student Association (TSA), included many changes aimed at improving teaching at Technion.
In addition, in 2012 Prof. Lavie instituted the Yanai Prize for Excellence in Academic Education, with the generous donation of Technion alumnus Moshe Yanai. The prize, which is awarded in recognition and appreciation of faculty members who set an example by their contributions to teaching and learning, has already become synonymous with excellence in teaching at Technion and has been awarded to 62 faculty members and three faculties.
http://www.technion.ac.il/en/2017/05/president-prof-peretz-lavie-elected-to-3rd-term/
Posted in Interviews with Scientific Leaders | Leave a Comment »
Right Internal Carotid Artery Clot Aspiration: 4.5 Minute Thrombectomy Using the ADAPT-FAST Technique and the ACE68 Catheter
Reporter: Aviva Lev-Ari, PhD, RN
WATCH VIDEO
Posted in Carotid Artery | Leave a Comment »
Professor Asher Cohen, was elected President of the Hebrew University of Jerusalem
Reporter: Aviva Lev-Ari, PhD, RN

WordCloud Image Produced by Adam Tubman
Professor Asher Cohen CV
https://scholars.huji.ac.il/jbc/people/prof-asher-cohen-0
-
Hebrew University Search Committee Recommends Rector Asher Cohen for President

May 17, 2017 — Following a rigorous search process, the presidential search committee has unanimously recommended that the university’s Rector, Professor Asher Cohen, be elected President of the Hebrew University of Jerusalem. The recommendation will be brought for approval to the Board of Managers and the Executive Committee.
As Rector of the Hebrew University for the past five years, Professor Cohen led a number of important processes. These include recruiting top researchers from Israel and around the world and providing them with the tools to stand at the forefront of global research, refreshing the university’s curricula and developing innovative programs that combine diverse disciplines, and increasing the university’s international cooperation and student and staff exchanges with leading institutions around the world.
After graduating with a B.A. in Economics and an M.A. in Psychology from the Hebrew University, Professor Cohen did his doctoral and post-doctoral studies at the University of Oregon in the United States. He served as a senior lecturer at Indiana University before returning in the early 1990s to the Hebrew University’s Department of Psychology, in the Faculty of Social Sciences. From 2008 to 2012, he served as the head of the Department of Psychology. He also held various leadership positions at the University, including being elected by his peers to serve as head of the Association of University Professors.
Professor Cohen’s research in the cognitive sciences focuses on the relationship between the human perception system and human response mechanisms, in situations that require very fast motor responses. In the framework of his research, Professor Cohen developed a theoretical model that successfully predicts in which situations performing two tasks will lead to a decline in abilities.
SOURCE
Posted in Interviews with Scientific Leaders | Leave a Comment »
Less is More: Minimalist Mitral Valve Repair: Expert Opinion of Prem S. Shekar, MD, Chief, Division of Cardiac Surgery, BWH – #7, 2017 Disruptive Dozen at #WMIF17
Reporter: Aviva Lev-Ari, PhD, RN

WordCloud Image Produced by Adam Tubman
Highlights LIVE Day 3: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017 BOSTON, MA • UNITED STATES
11:45 am – 12:45 pm
Boston Scientific Ballroom
Boston Scientific Ballroom
Disruptive Dozen: 12 Technologies that will reinvent Cardiovascular Care
Moderator: Calum MacRae, MD, PhD
12. Aging and Heart Disease: Can we reverse the process?
11.Nanotechnologies for Cardiac Diagnosis and Treatment
10. Breaking the Code: Diagnosis and Therapeutic Potential of RNA
9. Expanding the Pool of Organs for Transplant
8. Finding Cancer therapies without Cardiotoxicity
7. Less is more: Minimalist Mitral Valve Repair
6. Understanding Why exercise works for Just about every thing
5. Power Play: The Future of Implantable Cardiac Devices
4. Adopting the Orphan of Heart Disease
3. Targeting Inflammation in cardiovascular Disease
2. Harnessing Big Data and Deep Learning for Clinical Decision Support
- Quantitative Molecular Imaging for Cardiovascular Phynotypes
SOURCE
Excerpts from Prem S. Shekar, MD Presentation
The success achieved with TAVR
- least traumatic
- short recovery
- quicker return to normal lifestyle
encouraged Medical devices Manufacturers to develop Mitral Valve Repair technologies to address the large unmet need for percutaneous treatment of patients with Mitral Valve disease:
Mild or Severe (4 Million in the US, alone).
- Mitral Regurgitation (MR) – imperfect closure of the valve permits blood from LV to return back towards the lungs.
Causes for MR
- the degenerative myxomatous disease
- senile calcific degenerative disease causing enlargement of the LV, infection or Trauma.
- Mitral stenosis – narrowing of the valve
Causes for Mitral Stenosis
- rheumatic fever
- senile calcific degeneration – obstruction to the forward flow of blood resulting in increased fluid pressure inside the lungs.
Symptoms of MR – managed by drugs or Surgery for correction (Open Heart surgery or MIS – both procedures require use of bypass machine, the heart been stopped for the duration of repair/replacement) for Valve Repair or Valve Replacement
- shortness of breath
- fatigue
Uncorrected Mitral Valve disease can lead to
- irregular heart rhythms
- increased risk for stroke
- CHF
- Death
Transcatheter Mitral Valve Correction
- Valve replacement
- use of Repair devices on the Mitral leaflets
- implantation of neochords
- remodeling of the mitral annulus
Comparison of TARV with Transcatheter Mitral Valve Correction
- Aortic Valve vs Mitral Valve: difference in complexity and artistic nature of Mitral repair
- Ability to perform a Percutaneous repair on a Mitral Valve with same degree of accuracy and reproducibility as a Percutaneous repair on an Aortic Valve — will remain a challenge.
- development of advance imaging technologies will play a key role in achieveing success with Percutaneous repair on a Mitral Valve
- Percutaneous repair on a Mitral Valve need to overcome the complex structure and integrated relationship with the LV.
Leading Challenges in the Development of Percutaneous repair on a Mitral Valve Technologies
- Mitral is a bigger Valve than the Aortic
- It is more difficult to access
- It is Asymmetrical
- It lacks an anatomically well-defined annulus to which to anchor the artificial valve
- Its geometry changes throughout the cardiac cycle
- Placement of a replacement valve bears the risk of LV outflow tract obstruction
Patient Candidate Profile forPercutaneous repair on a Mitral Valve
- Patient with a failed Mitral Valve bioprosthesis – Severe Mitral Valve Disease
- Failed Mitral Valve Repairs
- Senile calcific degeneration
- Mitral Regurgitation unmanaged by medication
- Variable surgical risk related to co-morbidities
Other related articles on Mirtal Valve Disease covered in this Open Access Online Scientific Journal Include the following:
Search Category:
Cardiovascular Medical Devices: Cardiac Surgery, Cardiothoracic Surgical Procedures and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty – 248 articles
Mitral Valve Repair: Who is a Patient Candidate for a Non-Ablative Fully Non-Invasive Procedure? – Last Updated on 4/8/2017
Justin Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN
Lev-Ari, A. 5/19/2014. Transcatheter Mitral Valve (TMV) Procedures: Centers for Medicare & Medicaid Services (CMS) proposes to cover Transcatheter Mitral Valve Repair (TMVR)
Lev-Ari, A. 1/26/2014. Transcatheter Valve Competition in the United States: Medtronic CoreValve infringes on Edwards Lifesciences Corp. Transcatheter Device Patents
Lev-Ari, A. 1/26/2014. Developments on the Frontier of Transcatheter Aortic Valve Replacement (TAVR) Devices
Larry H. Bernstein and Aviva Lev-Ari 6/23/2013 Survivals Comparison of Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty
Larry H Bernstein and Lev-Ari, A. 6/23/2013 First case in the US: Valve-in-Valve (Aortic and Mitral) Replacements with Transapical Transcatheter Implants – The Use of Transfemoral Devices.
Larry H Bernstein and Lev-Ari, A. 6/17/2013 Transcatheter Aortic Valve Replacement (TAVR): Postdilatation to Reduce Paravalvular Regurgitation During TAVR with a Balloon-expandable Valve
Larry H Bernstein and Lev-Ari, A. 6/17/2013 Trans-apical Transcatheter Aortic Valve Replacement in a Patient with Severe and Complex Left Main Coronary Artery Disease (LMCAD)
Larry H Bernstein and Lev-Ari, A. 6/18/2013 Ventricular Assist Device (VAD): A Recommended Approach to the Treatment of Intractable Cardiogenic Shock
Larry H Bernstein and Lev-Ari, A.6/20/2013 Phrenic Nerve Stimulation in Patients with Cheyne-Stokes Respiration and Congestive Heart Failure
Lev-Ari, A. 2/12/2013 Clinical Trials on transcatheter aortic valve replacement (TAVR) to be conducted by American College of Cardiology and the Society of Thoracic Surgeons
Lev-Ari, A. 12/31/2012 Renal Sympathetic Denervation: Updates on the State of Medicine
Lev-Ari, A. 9/2/2012 Imbalance of Autonomic Tone: The Promise of Intravascular Stimulation of Autonomics
Lev-Ari, A. 8/13/2012Coronary Artery Disease – Medical Devices Solutions: From First-In-Man Stent Implantation, via Medical Ethical Dilemmas to Drug Eluting Stentshttps://pharmaceuticalintelligence.com/2012/08/13/coronary-artery-disease-medical-devices-solutions-from-first-in-man-stent-implantation-via-medical-ethical-dilemmas-to-drug-eluting-stents/
Lev-Ari, A. 7/18/2012Percutaneous Endocardial Ablation of Scar-Related Ventricular Tachycardia
Lev-Ari, A. 6/13/2012Treatment of Refractory Hypertension via Percutaneous Renal Denervation
Lev-Ari, A. 6/22/2012Competition in the Ecosystem of Medical Devices in Cardiac and Vascular Repair: Heart Valves, Stents, Catheterization Tools and Kits for Open Heart and Minimally Invasive Surgery (MIS)
Lev-Ari, A. 6/19/2012Executive Compensation and Comparator Group Definition in the Cardiac and Vascular Medical Devices Sector: A Bright Future for Edwards Lifesciences Corporation in the Transcatheter Heart Valve Replacement Market
Lev-Ari, A. 6/22/2012Global Supplier Strategy for Market Penetration & Partnership Options (Niche Suppliers vs. National Leaders)in the Massachusetts Cardiology & Vascular Surgery Tools and Devices Market for Cardiac Operating Rooms and Angioplasty Suites
Lev-Ari, A. 7/23/2012Heart Remodeling by Design: Implantable Synchronized Cardiac Assist Device: Abiomed’s Symphony
Lev-Ari, A. (2006b). First-In-Man Stent Implantation Clinical Trials & Medical Ethical Dilemmas. Bouve College of Health Sciences, Northeastern University, Boston, MA 02115
Posted in Cardiac and Cardiovascular Surgical Procedures, Interviews with Scientific Leaders, Mitral Valve: Repair and Replacement, PCI | Leave a Comment »
Source Articles on Perception of Care: Delivery of Care – External Sources
Reporter and Curator: Larry H. Bernstein, MD, FCAP
Delivery of Care – External Sources – Intentionally are Left as References in Live Links.
- Track, trigger and teamwork: Communication of deterioration in acute medical and surgical wards Article
Intensive and Critical Care Nursing, Volume 26, Issue 1, Pages 10-17
Donohue, L.A.; Endacott, R.
Cited by Scopus (19) - Communication interaction in ICU-Patient and staff experiences and perceptions Article
Intensive and Critical Care Nursing, Volume 22, Issue 3, Pages 167-180
Magnus, V.S.; Turkington, L.
Cited by Scopus (39) - Nursing care in a high-technological environment: Experiences of critical care nurses Article
Intensive and Critical Care Nursing, Volume 31, Issue 2, Pages 116-123
Tunlind, A.; Granstrom, J.; Engstrom, A. - Knowledge, attitudes and barriers towards prevention of pressure ulcers in intensive care units: A descriptive cross-sectional study Article
Intensive and Critical Care Nursing, Volume 26, Issue 6, Pages 335-342
Strand, T.; Lindgren, M. - Rehabilitation during mechanical ventilation: Review of the recent literature Review article
Intensive and Critical Care Nursing, Volume 31, Issue 3, Pages 125-132
Ntoumenopoulos, G. - Reducing risk for ventilator associated pneumonia through nursing sensitive interventions Article
Intensive and Critical Care Nursing, Volume 29, Issue 5, Pages 261-265
Micik, S.; Besic, N.; Johnson, N.; Han, M.; Hamlyn, S.; Ball, H. - The lived experiences of adult intensive care patients who were conscious during mechanical ventilation: A phenomenological-hermeneutic study Article
Intensive and Critical Care Nursing, Volume 28, Issue 1, Pages 6-15
Karlsson, V.; Bergbom, I.; Forsberg, A. - Families’experiences of their interactions with staff in an Australian intensive care unit (ICU): A qualitative study Article
Intensive and Critical Care Nursing, Volume 31, Issue 1, Pages 51-63
Wong, P.; Liamputtong, P.; Koch, S.; Rawson, H. - Experiences of critically ill patients in the ICU Article
Intensive and Critical Care Nursing, Volume 24, Issue 5, Pages 300-313
Hofhuis, J.G.M.; Spronk, P.E.; van Stel, H.F.; Schrijvers, A.J.P.; Rommes, J.H.; Bakker, J.
Cited by Scopus (54)
Posted in Patient’s Voice: Personal Experience with Invasive Medical Procedures | Leave a Comment »
LPBI Group introduces to our Marketing Channels The Pekama IP Community, a Global Group of Intellectual Property Experts using Community’s Proprietary Technology
Reporter: Aviva Lev-Ari, PhD, RN
The Pekama IP Community is a global group of intellectual property experts who work with each other on preferred terms and using our proprietary technology.
IP firms and IP experts participate in the Pekama IP community to bring networking, efficiency and predictability to their work.
IP experts are welcome to join the Pekama IP Community.
https://community.pekama.com/
Press Coverage is a Service that LPBI Group offers to Biotech and Medicine, Scientific and Business Conference Organizers.
LPBI Group’s Channels for e-Marketing of Biotech Contents
-
Our Journal has 1,215,606 eReaders on 5/16/2017, for All Time
http://pharmaceuticalintelligence.com
- Aviva’s – +6200 BIOTECH followers on LinkedIn
http://www.linkedin.com/in/avivalevari
- Aviva is a Member of 60 LinkedIn Groups in Biotech related fields
https://www.linkedin.com/groups/my-groups
- LPBI Group’s FaceBook Page
http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence
- LPBI Group’s Twitter Account
- Aviva Manages three Groups on LinkedIn
Cardiovascular Biotech & Pharma UK & US Networking Group
https://www.linkedin.com/groups/4357927
Leaders in Pharmaceutical Business Intelligence
https://www.linkedin.com/groups/4346921
Innovation in Israel
https://www.linkedin.com/groups/2987122
- LPBI Group’s Company’s Page on LinkedIn
Other articles related to International Property published in this Open Access Online Scientific Journal include the following:
Archive for the ‘Intellectual Property’ Category – 53 articles
Archive for the ‘Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough’ Category – 85 articles
Posted in Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough | Leave a Comment »


